Use of tylvalosin as antiviral agent
AssigneesCambridge University Technical Services Limited, Eco Animal Health Limited
InventorsAlbert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
Claims3
A method of treating a virus infection comprising administering tylvalosin or salts or esters thereof, or a pharmaceutical composition comprising tylvalosin or salts or esters thereof, to a subject having a viral infection wherein the virus is porcine reproductive and respiratory system virus (PRRSV) that uses the late endosomal or lysosomal pathway to infect cells.
A method of treating a porcine reproductive and respiratory system virus infection comprising administering tylvalosin or salts or esters thereof, or a pharmaceutical composition comprising tylvalosin or salts or esters thereof, to a subject having a porcine reproductive and respiratory system viral infection.
Dependencies are inferred from the claim text.